NPN & NHP Regulatory FAQ PinPoint North

The following information is typically required for us to prepare your NPN application package:

• NPN holder's name and contact information

• Formula details, including all medicinal ingredients and excipients (non-medicinal ingredients)

• The dosage form (e.g., capsule, tablet, liquid) and recommended dosage

• Desired health claims or recommended uses

• Evidence supporting the safety and efficacy of your product claims (e.g., published studies, monograph references)

• Proposed product label (draft is acceptable at initial stages)

• Any ingredient-specific information, such as certificates of analysis or safety data sheets

• Site License information for your manufacturer, packager, or importer

Our team will guide you through each requirement and identify any gaps before submission.

We provide end-to-end support for your NPN application, including:

• Regulatory classification assessment (Class I, II, or III)

• Evidence review and scientific rationale preparation

• Full documentation compilation and formatting

• Label review for Health Canada compliance

• Submission management and Health Canada correspondence

• Responses to Information Requests (IRNs) and Quality Technical Agreements (QTAs)

• Post-approval amendment and notification support

We handle all communication with Health Canada on your behalf, keeping you informed with updates within 1 business day and comprehensive responses within 3 business days.

Testing requirements depend on your product's classification and claims. Generally, Health Canada may require:

• Finished product testing: Potency, purity, and identity testing for medicinal ingredients

• Microbial testing: To ensure the product meets safety standards

• Heavy metals testing: Required for certain ingredient categories

• Stability testing: To support the product's shelf life and storage claims

For Class I products using monograph-compliant ingredients, testing requirements may be less extensive. Class II and III products with novel claims or complex formulations typically require more rigorous evidence. PinPoint North will identify exactly what is needed for your specific product during our initial regulatory assessment.

The timeline varies depending on the application class:

• Class I applications: Health Canada targets a review period of approximately 10 days, though actual timelines can vary

• Class II applications: Typically 60 to 210 days depending on complexity

• Class III applications: Can range from several months to over a year due to the detailed evidence review required

Preparation time before submission also depends on how quickly the required documentation and evidence can be compiled. PinPoint North works to minimize pre-submission delays and prepares complete, accurate submissions to reduce the risk of Information Requests that extend the review timeline.

Yes. Amazon Canada requires that all natural health products listed on its platform hold a valid Natural Product Number (NPN) issued by Health Canada. Products sold without an NPN are not compliant with Canadian regulations and can be removed from Amazon listings or result in compliance action.

This applies to sellers based in Canada and international sellers shipping into the Canadian market. If you are planning to sell supplements, vitamins, herbal products, or other NHPs through Amazon Canada, securing your NPN is a mandatory first step.

The NPN application process involves detailed regulatory requirements that differ significantly from other markets such as the United States. Common challenges include:

• Selecting the correct product classification (Class I, II, or III), which determines the evidence standard

• Identifying which Health Canada monographs apply to your ingredients and claims

• Structuring evidence dossiers to meet Health Canada's standards

• Preparing bilingual labels that meet all mandatory format and content requirements

• Responding to Information Requests (IRNs) from Health Canada without causing delays

Errors or incomplete submissions result in refusals or extended review timelines. An experienced NHP consultant helps ensure your submission is complete, strategically structured, and aligned with current Health Canada expectations from the start.

The NPN license is issued to the NPN holder, which is the company or individual who submitted the application and is responsible for the product in the Canadian market. This is typically the Canadian importer, distributor, or brand owner — not necessarily the manufacturer.

If you are an international manufacturer, you will generally need a Canadian entity to act as the NPN holder. PinPoint North can advise you on the appropriate licensing structure for your business model.

An NPN itself does not have a fixed expiry date. However, the license can become invalid if:

• The product formula, label, or other licensed details change without filing the required amendment or notification with Health Canada

• The NPN holder fails to maintain compliance with Good Manufacturing Practices (GMP) requirements

• Health Canada initiates a compliance review and finds the product no longer meets its standards

It is important to notify Health Canada within 60 days of implementing any minor changes (notifications) and to obtain prior approval for significant changes (amendments) to keep your NPN valid.

Any changes to a licensed natural health product must be reported to Health Canada. The type of report depends on the significance of the change:

Amendments (require Health Canada approval before implementation) apply to significant changes such as:

• Changes to medicinal ingredients, source, or potency

• Modifications to recommended dosage or duration of use

• Updates to risk information, warnings, or adverse reaction statements

• Changes to product specifications or test methods

Notifications (must be filed within 60 days of implementation) apply to minor changes such as:

• Brand name updates

• Adding or substituting non-medicinal ingredients

• Updating common names of medicinal ingredients

• Adding new warnings or safety information

PinPoint North includes two complimentary notifications within the first nine months after your NPN approval to help you manage early post-licensing changes.

Health Canada's review timelines by class are:

• Class I: Target of approximately 10 business days (licence applications based on pre-assessed monograph ingredients)

• Class II: Approximately 60 days for straightforward submissions; more complex applications may take longer

• Class III: Can range from several months to over 12 months depending on the complexity of evidence required

These are Health Canada's internal targets and actual timelines may vary based on submission volume and the completeness of your application. Incomplete applications that receive Information Requests (IRNs) will take significantly longer. A well-prepared, complete submission is the most effective way to minimize review time.

The evidence required depends on the type of claim and your product's classification:

• Class I (Monograph-based): Your ingredients and claims must align with a Health Canada pre-approved monograph. No additional clinical studies are required if the monograph conditions are fully met.

• Class II: Requires references to published studies, traditional use evidence, or pharmacopeial standards supporting the safety and efficacy of your claims.

• Class III (Non-traditional or novel claims): Requires robust clinical or scientific evidence demonstrating safety and efficacy. This is the most demanding evidence standard.

Health Canada accepts evidence from peer-reviewed studies, authoritative texts, traditional use documentation, and recognized pharmacopeias. PinPoint North will identify the appropriate evidence strategy for your specific product and claims during the regulatory assessment phase.

While Health Canada sets its own internal review timelines, PinPoint North accelerates what is within your control:

• We prepare complete, accurate submissions from the start, minimizing the risk of Information Requests that cause significant delays

• We respond rapidly to any Health Canada queries (updates within 1 business day)

• We identify the most efficient regulatory pathway for your product classification

• We resolve potential issues during the pre-submission phase before they become obstacles during review

The fastest path to NPN approval is a well-prepared first submission. Our structured approach is specifically designed to achieve this.

No. Canadian NHP labeling requirements are distinct from U.S. FDA requirements and are not interchangeable. Key differences include:

• Bilingual labeling: All mandatory information on Canadian NHP labels must appear in both English and French

• Different mandatory elements: Health Canada requires specific label elements such as the NPN number, recommended use, directions for use, cautions, and a list of medicinal and non-medicinal ingredients in the prescribed format

• Different terminology: Terms such as "Supplement Facts" used in the U.S. are not used in Canada; Canadian labels use "Medicinal Ingredients" and follow a different table format

• Claim restrictions: Claims permitted under FDA regulations may not be permitted under Health Canada's NHP Regulations

A full label redesign and compliance review is required before marketing in Canada. PinPoint North provides bilingual label compliance review as part of our NPN application service.

No. Health Canada does not permit proprietary blends on NHP labels. All medicinal ingredients must be individually declared with their specific quantities per dosage unit. This is a significant difference from U.S. dietary supplement labeling, where proprietary blends are permitted.

If your product currently uses a proprietary blend format, your label will need to be restructured to meet Canadian requirements before an NPN can be approved.

Yes. All mandatory label information on natural health products sold in Canada must appear in both English and French. This includes:

• Product name and recommended use

• Medicinal and non-medicinal ingredients

• Dosage directions and cautions

• Storage conditions and lot number information

• Name and address of the NPN holder

Optional marketing language does not need to be bilingual, but all regulatory-required content must be. Non-compliant bilingual labeling is a common cause of NPN application delays and post-market compliance issues. PinPoint North's label compliance review ensures your label meets all bilingual requirements before submission.

If your product is manufactured in Canada, you do not need an importer of record for products destined for the Canadian market. However:

• Your Canadian manufacturing facility must hold a valid Natural Health Product Site License with the appropriate activities listed (e.g., manufacturing, packaging, labeling)

• The facility must operate under Good Manufacturing Practices (GMP) as required by Health Canada

If your product is manufactured outside of Canada and imported into Canada, a Canadian importer holding a Site License with import activity is required.

PinPoint North provides Site License support for both manufacturers and importers to ensure the correct licensing structure is in place before NPN submission.

Phone: 647-975-5507

Email: info@pinpointnorth.com

WhatsApp: +1 647-975-5507